Inhibrx Biosciences (INBX) Financial Statements

Price: $11.32
Market Cap: $163.87M
Avg Volume: 111.26K
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: -1.0920762
52W Range: $10.8-18.95
Website: Inhibrx Biosciences

Overview of Financial Statements

Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:

  • Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
  • Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
  • Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.

This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Inhibrx Biosciences.


Income Statement

Revenue
Cost of Revenue
Revenue and Costs$80.00M$80.00M$60.00M$60.00M$40.00M$40.00M$20.00M$20.00M$0.00$0.00201720172018201820192019202020202021202120222022202320232024202420252025
Operating Expenses
Operating Income
Operating Expenses & Income$400.00M$400.00M$200.00M$200.00M$0.00$0.00-$200.00M-$200.00M-$400.00M-$400.00M201720172018201820192019202020202021202120222022202320232024202420252025
Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019 December 31, 2018 December 31, 2017 December 31, 2016
Revenue $200.00K $1.80M $2.18M $7.12M $12.81M $9.09M $7.50M $7.95M $6.67M
Cost of Revenue $- $1.19M $2.85M $2.69M $73.50M $47.91M $33.45M $25.51M $16.99M
Gross Profit $200.00K $609.00K $-668.00K $4.44M $-60.69M $-38.81M $-25.95M $-17.56M $-10.32M
Gross Profit Ratio 100.00% 33.83% -30.67% 62.27% -473.82% -426.86% -346.05% -220.88% -154.87%
Research and Development Expenses $203.74M $190.65M $110.19M $71.44M $73.50M $47.91M $33.45M $25.51M $16.99M
General and Administrative Expenses $127.91M $29.38M $21.12M $12.36M $6.84M $9.02M $4.65M $2.61M $1.82M
Selling and Marketing Expenses $- $- $- $- $- $- $- $- $-253.00K
Selling General and Administrative Expenses $127.91M $29.38M $21.12M $12.36M $6.84M $9.02M $4.65M $2.61M $1.57M
Other Expenses $- $- $-14.00K $-106.00K $-80.00K $-4.12M $68.00K $24.00K $-
Operating Expenses $331.65M $219.83M $131.29M $83.69M $80.25M $52.81M $37.01M $27.68M $18.56M
Cost and Expenses $331.65M $221.02M $131.29M $83.69M $80.25M $52.81M $37.01M $27.68M $18.81M
Interest Income $10.94M $11.92M $16.11M $5.22M $10.82M $5.72M $- $- $759.00K
Interest Expense $13.49M $31.84M $16.11M $5.22M $10.82M $5.72M $1.48M $2.13M $-
Depreciation and Amortization $2.29M $1.19M $1.23M $2.69M $2.39M $2.52M $676.00K $399.00K $253.00K
EBITDA $1.70B $-206.69M $-125.82M $-76.56M $-67.44M $-42.60M $-28.77M $-19.30M $-11.89M
EBITDA Ratio 851675.00% -11482.94% -5776.72% -1074.58% -526.57% -468.54% -383.59% -242.83% -178.39%
Operating Income $-331.45M $-219.22M $-129.12M $-76.56M $-67.44M $-43.71M $-29.51M $-19.73M $-12.15M
Operating Income Ratio -165724.00% -12178.94% -5928.24% -1074.58% -526.57% -480.74% -393.51% -248.15% -182.18%
Total Other Income Expenses Net $2.02B $-20.50M $-29.90M $-5.20M $-8.19M $-6.79M $-1.41M $-2.10M $-739.00K
Income Before Tax $1.69B $-239.72M $-145.22M $-81.77M $-75.63M $-50.50M $-30.93M $-21.83M $-12.88M
Income Before Tax Ratio 843787.00% -13318.00% -6667.72% -1147.59% -590.52% -555.39% -412.33% -274.59% -193.27%
Income Tax Expense $2.00K $3.00K $3.00K $2.00K $3.00K $898.00K $96.00K $250.00K $-4.62M
Net Income $1.69B $-241.36M $-145.23M $-81.77M $-75.64M $-51.40M $-31.16M $-19.44M $-8.27M
Net Income Ratio 843786.00% -13408.94% -6667.86% -1147.62% -590.54% -565.27% -415.51% -244.55% -124.03%
EPS $114.01 $-5.12 $-3.62 $-2.15 $-2.99 $-1.41 $-1.15 $-0.68 $-0.23
EPS Diluted $112.62 $-5.12 $-3.62 $-2.15 $-2.99 $-1.41 $-1.15 $-0.68 $-0.23
Weighted Average Shares Outstanding 14.80M 47.13M 40.11M 38.01M 25.26M 36.55M 27.08M 28.79M 36.55M
Weighted Average Shares Outstanding Diluted 14.98M 47.13M 40.11M 38.01M 25.26M 36.55M 27.08M 28.79M 36.55M
SEC Filing Source Source Source Source Source Source Source Source Source

Balance Sheet

Total Assets
Total Liabilities
Total Assets and Liabilities$320.00M$320.00M$240.00M$240.00M$160.00M$160.00M$80.00M$80.00M$0.00$0.00201720172018201820192019202020202021202120222022202320232024202420252025
Equity$180.00M$180.00M$120.00M$120.00M$60.00M$60.00M$0.00$0.00-$60.00M-$60.00M-$120.00M-$120.00M201720172018201820192019202020202021202120222022202320232024202420252025
Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019 December 31, 2018 December 31, 2017 December 31, 2016
Cash and Cash Equivalents $152.60M $277.92M $273.87M $131.30M $128.66M $11.54M $2.10M $13.47M $20.02M
Short Term Investments $- $- $- $- $- $- $- $- $-
Cash and Short Term Investments $152.60M $277.92M $273.87M $131.30M $128.66M $11.54M $2.10M $13.47M $20.02M
Net Receivables $397.00K $778.00K $257.00K $878.00K $615.00K $438.00K $690.00K $696.00K $-
Inventory $- $- $-257.00K $-878.00K $-129.28M $3.21M $2.31M $999.00K $-
Other Current Assets $7.41M $16.66M $5.51M $7.81M $132.17M $376.00K $553.00K $276.00K $383.00K
Total Current Assets $160.40M $295.36M $280.49M $139.11M $132.17M $15.56M $5.66M $15.44M $20.41M
Property Plant Equipment Net $13.54M $9.37M $7.22M $9.49M $11.32M $10.68M $2.59M $1.80M $864.00K
Goodwill $- $- $- $- $- $- $- $- $-
Intangible Assets $- $- $- $- $- $- $- $- $-
Goodwill and Intangible Assets $- $- $- $- $- $- $- $- $-
Long Term Investments $- $- $- $- $- $- $- $- $-
Tax Assets $- $- $- $- $- $- $- $- $-
Other Non-Current Assets $6.83M $3.16M $3.16M $1.85M $245.00K $245.00K $1.73M $- $-1
Total Non-Current Assets $20.37M $12.54M $10.38M $11.34M $11.57M $10.93M $4.33M $1.80M $864.00K
Other Assets $- $- $- $- $- $- $- $- $1
Total Assets $180.77M $307.89M $290.88M $150.45M $143.74M $26.49M $9.98M $17.25M $21.27M
Account Payables $9.24M $8.31M $4.34M $9.12M $13.46M $3.12M $6.53M $775.00K $167.00K
Short Term Debt $1.59M $4.13M $3.72M $1.67M $1.50M $4.67M $5.93M $5.17M $4.26M
Tax Payables $- $- $- $- $- $- $- $- $-
Deferred Revenue $- $- $166.00K $2.03M $3.08M $7.94M $1.63M $2.61M $-
Other Current Liabilities $29.89M $43.88M $19.35M $9.62M $13.36M $4.85M $2.09M $372.00K $856.00K
Total Current Liabilities $40.73M $56.31M $27.58M $22.45M $31.40M $20.57M $16.18M $8.92M $5.28M
Long Term Debt $6.45M $208.08M $205.24M $70.47M $35.95M $37.06M $3.56M $9.49M $14.66M
Deferred Revenue Non-Current $- $- $- $110.00K $737.00K $1.00M $- $- $-
Deferred Tax Liabilities Non-Current $- $- $- $-110.00K $- $- $- $- $-
Other Non-Current Liabilities $- $- $- $5.14M $180.00K $61.42M $47.88M $21.25M $92.00K
Total Non-Current Liabilities $6.45M $208.08M $205.24M $75.61M $36.87M $99.49M $51.45M $30.75M $14.75M
Other Liabilities $- $- $- $- $- $- $- $- $-
Total Liabilities $47.18M $264.39M $232.82M $98.07M $68.27M $120.06M $67.63M $39.67M $20.03M
Preferred Stock $- $- $- $150.45M $143.74M $59.51M $47.52M $- $-
Common Stock $1.00K $5.00K $4.00K $4.00K $4.00K $2.00K $3.00K $- $-
Retained Earnings $-106.13M $-613.73M $-372.37M $-227.15M $-145.38M $-69.25M $-17.86M $-28.77M $-9.25M
Accumulated Other Comprehensive Income Loss $- $0 $- $-150.45M $-143.74M $-59.51M $-1.71M $-1.03M $-
Other Total Stockholders Equity $239.72M $657.23M $430.43M $279.53M $220.85M $-24.32M $-85.61M $1.03M $-
Total Stockholders Equity $133.58M $43.50M $58.06M $52.38M $75.47M $-93.57M $-57.64M $-28.77M $-9.25M
Total Equity $133.58M $43.50M $58.06M $52.38M $75.47M $-93.57M $-57.64M $-22.42M $1.24M
Total Liabilities and Stockholders Equity $180.77M $307.89M $290.88M $150.45M $143.74M $26.49M $9.98M $17.25M $21.27M
Minority Interest $- $- $- $- $- $- $- $6.35M $10.49M
Total Liabilities and Total Equity $180.77M $307.89M $290.88M $150.45M $143.74M $26.49M $9.98M $17.25M $21.27M
Total Investments $- $- $- $- $- $- $- $- $-
Total Debt $8.05M $210.14M $202.07M $70.47M $37.45M $41.73M $9.49M $14.66M $18.92M
Net Debt $-144.55M $-67.78M $-71.80M $-60.83M $-91.21M $30.19M $7.39M $1.19M $-1.11M

Cash Flow Statement

Operating Cash Flow
Investing Cash Flow
Operating and Investing Cash Flow$0.00$0.00-$50.00M-$50.00M-$100.00M-$100.00M-$150.00M-$150.00M-$200.00M-$200.00M201720172018201820192019202020202021202120222022202320232024202420252025
Financing Cash Flow$300.00M$300.00M$240.00M$240.00M$180.00M$180.00M$120.00M$120.00M$60.00M$60.00M$0.00$0.00201720172018201820192019202020202021202120222022202320232024202420252025
Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019 December 31, 2018 December 31, 2017 December 31, 2016
Net Income $1.69B $-239.73M $-145.23M $-81.77M $-76.12M $-51.40M $-31.02M $-22.08M $-8.27M
Depreciation and Amortization $2.29M $1.19M $1.23M $1.20M $1.02M $1.16M $676.00K $399.00K $253.00K
Deferred Income Tax $- $- $- $-9.00K $-2.14M $1.08M $- $- $-
Stock Based Compensation $58.52M $24.85M $17.79M $15.05M $5.02M $3.97M $2.48M $1.18M $552.00K
Change in Working Capital $52.05M $15.35M $3.16M $-17.52M $12.69M $3.48M $4.25M $999.00K $-6.28M
Accounts Receivables $381.00K $-521.00K $130.00K $-167.00K $117.00K $491.00K $-550.00K $-140.00K $-
Inventory $- $- $- $-11.03M $7.76M $-2.47M $-672.00K $1.09M $-
Accounts Payables $17.90M $2.11M $-705.00K $-4.64M $10.43M $-3.47M $4.91M $608.00K $68.00K
Other Working Capital $33.77M $13.76M $3.74M $-1.67M $-5.61M $8.94M $556.00K $-556.00K $-6.35M
Other Non Cash Items $-1.99B $5.03M $5.09M $2.73M $11.56M $9.61M $522.00K $746.00K $-3.37M
Net Cash Provided by Operating Activities $-194.41M $-193.31M $-115.30M $-80.32M $-47.97M $-32.08M $-23.09M $-18.75M $-18.11M
Investments in Property Plant and Equipment $-2.60M $-4.59M $-686.00K $-864.00K $-1.36M $-1.81M $-1.43M $-1.34M $-215.00K
Acquisitions Net $- $- $- $55.00K $- $- $- $- $-
Purchases of Investments $- $- $- $- $- $- $- $- $-
Sales Maturities of Investments $- $- $- $- $- $- $- $- $-
Other Investing Activities $- $- $- $55.00K $- $- $- $- $-
Net Cash Used for Investing Activities $-2.60M $-4.59M $-686.00K $-809.00K $-1.36M $-1.81M $-1.43M $-1.34M $-215.00K
Debt Repayment $- $- $- $- $- $- $- $- $-
Common Stock Issued $- $201.96M $127.37M $40.20M $136.85M $11.99M $20.36M $- $-
Common Stock Repurchased $- $- $- $- $- $- $- $- $-
Dividends Paid $- $- $- $- $- $- $-828.00K $-1.38M $-
Other Financing Activities $71.68M $201.96M $128.81M $83.77M $166.46M $43.33M $13.98M $14.91M $28.77M
Net Cash Used Provided by Financing Activities $71.68M $201.96M $258.55M $83.77M $166.46M $43.33M $13.15M $13.54M $28.77M
Effect of Forex Changes on Cash $- $- $- $- $- $- $- $- $-
Net Change in Cash $-125.33M $4.06M $142.56M $2.64M $117.12M $9.44M $-11.37M $-6.55M $10.45M
Cash at End of Period $152.60M $277.92M $273.87M $131.30M $128.66M $11.54M $2.10M $13.47M $20.02M
Cash at Beginning of Period $277.92M $273.87M $131.30M $128.66M $11.54M $2.10M $13.47M $20.02M $9.58M
Operating Cash Flow $-194.41M $-193.31M $-115.30M $-80.32M $-47.97M $-32.08M $-23.09M $-18.75M $-18.11M
Capital Expenditure $-2.60M $-4.59M $-686.00K $-864.00K $-1.36M $-1.81M $-1.43M $-1.34M $-215.00K
Free Cash Flow $-197.01M $-197.90M $-115.99M $-81.19M $-49.33M $-33.89M $-24.52M $-20.09M $-18.32M